Summary

The global human chorionic gonadotropin (HCG) market size reached USD 1,038.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,853.6 Million by 2033, exhibiting a growth rate (CAGR) of 6.32% during 2025-2033. The rising incidences of infertility in women, increasing prevalence of hypogonadism-related disorders, and production of HCG using recombinant technology represent some of the key factors driving the market.

Human chorionic gonadotropin (HCG) is a chemical produced by syncytiotrophoblastic cells of the placenta during pregnancy. It is found in blood, urine, liver, colon, and pituitary glands. HCG stimulates the corpus luteum to produce progesterone to maintain the pregnancy. It is extracted and purified from the urine of pregnant women for clinical applications using various techniques, such as ion exchange chromatography, dye-affinity chromatography, nanofiltration, and reverse-phase high-performance liquid chromatography (HPLC). HCG is widely used to treat infertility, increase the chances of pregnancy, help in the production of testosterone and sperm, and treat cryptorchidism in male children. It also aids in diagnosing and monitoring pregnancy-related disorders, prenatal screening, and gynecological cancers.

Human Chorionic Gonadotropin (HCG) Market Trends:
The rising incidences of infertility among females due to uterine disorders, blocked fallopian tube, polycystic ovarian syndrome (PCOS), and endocrine system disorders are among the key factors driving the market growth. HCG is widely used in various assisted reproductive technologies, such as in-vitro fertilization (IVF) and intrauterine insemination (IUI), to treat female infertility, as it aids in inducing ovulation, promotes the formation of the embryo, facilitates correct timing of oocyte retrieval, increases endometrial thickness, and improve endometrial receptivity. In addition to this, the widespread product utilization in combination with other fertility drugs to increase the chances of pregnancy in women is acting as another growth-inducing factor. Furthermore, the increasing application of HCG to improve testosterone levels, enhance fertility, and promote sexual function due to the increasing prevalence of hypogonadism-related disorders in males suffering from obesity and type 2 diabetes is favoring the market growth. Additionally, the production of HCG using recombinant technology that provides identical properties, enhanced efficacy, and improved safety compared to naturally sourced HCG and enhances patient tolerance is positively influencing the market growth. Other factors, including the rapid development of healthcare infrastructure, increasing availability of treatment and services regarding infertility, rising geriatric population, extensive research and development (R&D) activities for the launch of novel purification and extraction technologies, and the implementation of various government initiatives to improve the sexual health of people, are anticipated to drive the market growth further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global human chorionic gonadotropin (HCG) market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on technology, therapeutic area, and end user.

Technology Insights:

Natural Source Extraction
Recombinant Technology

The report has also provided a detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the technology. This includes natural source extraction and recombinant technology. According to the report, natural source extraction represented the largest segment.

Therapeutic Area Insights:

Female Infertility Treatment
Male Hypogonadism
Oligospermic Treatment
Others

A detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the therapeutic area has been provided in the report. This includes female infertility treatment, male hypogonadism, oligospermic treatment, and others. According to the report, female infertility treatment accounted for the largest market share.

End User Insights:

Fertility Clinics
Research Institutions
Others

A detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the end user has been provided in the report. This includes fertility clinics, research institutions, and others. According to the report, fertility clinics accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for human chorionic gonadotropin (HCG). Some of the factors driving the North America human chorionic gonadotropin (HCG) market include rising incidences of infertility among women, growing consumer awareness regarding the available treatment for infertility and gynecological concerns, and rising expenditure capacities of consumers.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global human chorionic gonadotropin (HCG) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Biocare Medical LLC, Ferring Pharmaceuticals, Fresenius SE & Co. KGaA, Kamiya Biomedical Company (Nitto Boseki Co. Ltd.), Lee Biosolutions Inc. (Oy Medix Biochemica Ab), Merck & Co. Inc., Prospec-Tany Technogene Ltd., Scripps Laboratories Inc., Sun Pharmaceutical Industries Limited, etc.

Key Questions Answered in This Report:
How has the global human chorionic gonadotropin (HCG) market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global human chorionic gonadotropin (HCG) market?
What are the key regional markets?
Which countries represent the most attractive human chorionic gonadotropin (HCG) markets?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the therapeutic area?
What is the breakup of the market based on the end user?
What is the competitive structure of the global human chorionic gonadotropin (HCG) market?
Who are the key players/companies in the global human chorionic gonadotropin (HCG) market?

ページTOPに戻る

Table of Contents

​1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Human Chorionic Gonadotropin (HCG) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Natural Source Extraction
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Recombinant Technology
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapeutic Area
7.1 Female Infertility Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Male Hypogonadism
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Oligospermic Treatment
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Fertility Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Institutions
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Biocare Medical LLC
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Ferring Pharmaceuticals
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Fresenius SE & Co. KGaA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Kamiya Biomedical Company (Nitto Boseki Co. Ltd.)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Lee Biosolutions Inc. (Oy Medix Biochemica Ab)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Prospec-Tany Technogene Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Scripps Laboratories Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Sun Pharmaceutical Industries Limited
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Human Chorionic Gonadotropin Market: Major Drivers and Challenges
Figure 2: Global: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Human Chorionic Gonadotropin Market: Breakup by Technology (in %), 2024
Figure 5: Global: Human Chorionic Gonadotropin Market: Breakup by Therapeutic Area (in %), 2024
Figure 6: Global: Human Chorionic Gonadotropin Market: Breakup by End User (in %), 2024
Figure 7: Global: Human Chorionic Gonadotropin Market: Breakup by Region (in %), 2024
Figure 8: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Human Chorionic Gonadotropin (Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Human Chorionic Gonadotropin (Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Human Chorionic Gonadotropin (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Human Chorionic Gonadotropin (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: North America: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: North America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: United States: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: United States: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Canada: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Canada: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Asia-Pacific: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Asia-Pacific: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: China: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: China: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Japan: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Japan: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: India: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: India: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: South Korea: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: South Korea: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Australia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Australia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Indonesia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Indonesia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Europe: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Europe: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Germany: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Germany: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: France: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: France: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United Kingdom: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United Kingdom: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Italy: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Italy: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Spain: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Spain: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Russia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Russia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Latin America: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Latin America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Brazil: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Brazil: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Mexico: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Mexico: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Middle East and Africa: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Middle East and Africa: Human Chorionic Gonadotropin Market: Breakup by Country (in %), 2024
Figure 74: Middle East and Africa: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Global: Human Chorionic Gonadotropin Industry: Drivers, Restraints, and Opportunities
Figure 76: Global: Human Chorionic Gonadotropin Industry: Value Chain Analysis
Figure 77: Global: Human Chorionic Gonadotropin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Human Chorionic Gonadotropin Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 3: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Therapeutic Area (in Million USD), 2025-2033
Table 4: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Human Chorionic Gonadotropin Market: Competitive Structure
Table 7: Global: Human Chorionic Gonadotropin Market: Key Players